Risk of suicide and suicidality in patients with moderate to severe psoriasis: results from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
Clinical and Experimental Dermatology · 2025
DOI: 10.1093/ced/llae449 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Kerry Williams und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Musculoskeletal and Dermatological Sciences, NIHR Manchester Biomedical Research Centre, The University of Manchester, Manchester, UK. Hauptthemen laut MEDLINE: Psoriasis, Suicide. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Association of Dermatologists Biologics Register Ltd, British Association of Dermatologists, Biologics and Immunomodulators Register.
Abstract (Originalsprache)
Background
Psoriasis is associated with poor mental health and reduced quality of life. Although the high risk for depression in patients with psoriasis is well established, the suicidality risk among these patients is uncertain. Previous studies provide contrasting results and have not included patients with clinically confirmed severe disease.
Objectives
To determine the risk of suicide among patients with moderate to severe psoriasis and to compare it with that of the general population, and to investigate if psychiatric comorbidity or history of suicidality increases future suicidality risk in psoriasis. We further estimated the incidence of suicidal and self-injurious behaviours in patients.
Methods
Analysis was performed using the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). General population mortality and suicide data were used as controls.
Results
There were nine suicides in BADBIR. The incidence rate of suicide was 12.5 per 100 000 person-years [95% confidence interval (CI) 6.53–24.11] in BADBIR vs. 11.0 per 100 000 person-years (95% CI 10.7–11.3) in the general population in England and Wales. Among patients, psychiatric comorbidity or past suicidality was associated with a higher risk for suicidal ideation, suicide attempts and self-injurious behaviours.
Conclusions
The suicide rate among patients with moderate to severe psoriasis was not significantly higher when compared with the general population. Suicide is a rare event and our results are limited by uncertainty about the reliability of the estimate. However, considering the high depression prevalence in psoriasis, our findings support the need for prompt assessment of patients for psychiatric comorbidities and suicidality history. Further research is required on suicidal behaviours and the role of psoriasis severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Musculoskeletal and Dermatological Sciences, NIHR Manchester Biomedical Research Centre, The University of Manchester, Manchester, UK.
- Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester, UK.
- Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.
- Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
- Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
- NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
ORCID-Profile: Georgia Lada, Richard B Warren, Olivia Hughes, Kayleigh Mason
Förderung
- British Association of Dermatologists Biologics Register Ltd
- British Association of Dermatologists
- Biologics and Immunomodulators Register
- AbbVie
- Almirall
- Bristol Myers Squibb
- Boehringer Ingelheim
- Eli Lilly
Zitieren
APA
Williams, K., Lada, G., Reynolds, N. J., Mcelhone, K., Evans, I., Warren, R. B., Walton, S., Hughes, O., Bewley, A., Mason, K., & Kleyn, C. E. (2025). Risk of suicide and suicidality in patients with moderate to severe psoriasis: results from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llae449
Vancouver
Williams K, Lada G, Reynolds NJ, Mcelhone K, Evans I, Warren RB, et al. Risk of suicide and suicidality in patients with moderate to severe psoriasis: results from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llae449
BibTeX
@article{Williams2025,
author = {Williams, Kerry and Lada, Georgia and Reynolds, Nick J and Mcelhone, Kathleen and Evans, Ian and Warren, Richard B and Walton, Shernaz and Hughes, Olivia and Bewley, Anthony and Mason, Kayleigh and Kleyn, C Elise},
title = {Risk of suicide and suicidality in patients with moderate to severe psoriasis: results from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)},
journal = {Clinical and Experimental Dermatology},
year = {2025},
doi = {10.1093/ced/llae449}
}
EUVIMED